Description
Tamoxifen Citrate Nolvadex
Tamoxifen Citrate (Nolvadex) is a SERM, or a Selective Estrogen Receptor Modulator that is commonly used as part of PCT, or Post Cycle Therapy to mitigate the effects of anabolic steroids. Novaldex is a well-established and effective treatment for oestrogen receptor-positive breast cancer. Four large randomised clinical trials have shown that tamoxifen reduces the incidence of oestrogen receptor-positive breast cancer in women at high risk of developing the disease.
| Nolvadex Tamoxifen | |
| CAS Number | 10540-29-1 |
| Molar Mass | 371.515 g/mol |
| Chemical Formula | C26H29NO |
| IUPAC Name | (Z)-2-[4-(1,2-Diphenylbut-1-enyl)phenoxy]-N,N-dimethylethanamine |
IML Affiliate Disclosure
Some links on IML may connect readers with third-party suppliers through affiliate arrangements. IML may receive compensation from qualifying transactions at no additional cost to the reader, but the third-party supplier remains responsible for the actual sale, fulfillment, and product documentation.
